NewGenIvf Group Ltd - Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing covers the month of July 2026 for NewGenIvf Group Limited, a foreign private issuer headquartered in Bangkok, Thailand. The report details a corporate action approved by the Board of Directors on May 4, 2026, regarding a reverse stock split.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document focuses exclusively on capital structure adjustments rather than operational financial performance.
Material Changes
- Reverse Stock Split: A 1-for-3 reverse stock split was approved for all issued and unissued shares (Class A Ordinary, Class B Ordinary, and Preferred shares).
- Share Count Reduction: The number of outstanding Class A Ordinary Shares will decrease from 10,259,764 to approximately 3,419,922.
- Effective Date: The split is effective at 12:01 a.m. (ET) on July 6, 2026.
- Trading Adjustments: Shares will trade on the Nasdaq Capital Market under the symbol "NIVF" with a new CUSIP number (G0544E501) starting July 6, 2026.
- Derivatives Adjustment: All outstanding options, warrants, and convertible securities will be adjusted by dividing the exercisable share count by three.
Guidance, Outlook, and Risks
The filing does not contain management commentary on future financial guidance, operational outlook, or specific risk factors beyond the mechanics of the stock split. The Board noted that no shareholder vote is required for this action under the BVI Business Companies Act and the Company's M&A. No fractional shares will be issued; instead, shareholders entitled to fractions will receive one full share.
Investor Verification Checklist
- Verify the new CUSIP number (G0544E501) for trading purposes on July 6, 2026.
- Confirm the adjusted share count in brokerage accounts post-split (1-for-3 ratio).
- Review the impact of the split on the exercise price and share quantity of any held options or warrants.
- Check for subsequent filings regarding the company's financial health, as this 6-K contains no operational data.